Reckitt Benckiser, Inc. FDA Inspection Record

FEI 1640689 · Inspections, Form 483s, warning letters and import refusals

Reckitt Benckiser, Inc. is an FDA-inspected facility (FEI 1640689) located in Fort Worth, TX, US. RegDataLab tracks 3 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Mar 4, 2013: Voluntary Action Indicated (VAI)
Inspections on record
3 (1 OAI, 2 VAI)
Last OAI inspection
Jan 5, 2011
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
4, latest Feb 2, 2011

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Mar 4, 2013Voluntary Action Indicated (VAI)Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Handling and Storage to Prevent Contamination (21 CFR 211.80(b))
Specific information required in individual logs (21 CFR 211.182)
Jan 5, 2011Official Action Indicated (OAI)Contract drug products--lack of responsibility (21 CFR 211.22(a))
Approve or reject procedures or specs (21 CFR 211.22(c))
Protective Apparel Not Worn (21 CFR 211.28(a))
Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
and 10 more
Feb 10, 2010Voluntary Action Indicated (VAI)Investigations of discrepancies, failures (21 CFR 211.192)
Manufacturing Instructions and Specifications (21 CFR 211.186(b)(9))
Complaint Investigation/Follow-Up Findings (21 CFR 211.198(b)(2))
Changes to Procedures Not Reviewed, Approved (21 CFR 211.100(a))
and 3 more

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Feb 2, 2011Class IIID-372-2011Delsym Night-Time Cough & Cold Liquid, 4 fl. oz., Dist. by: Reckitt Benckiser Inc…
Subpotent (Multiple Ingredient Drug): Product contains below the minimum specification limit
Feb 4, 2010Class IIID-374-2010Clearasil Ultra (2% Salicylic Acid) Overnight Wash, 6.78 fl.oz (200 mL), Item… and 1 more product
Product has potential for losing lot code information when unwrapped.
Jun 5, 2009Class IIID-1887-2009Mucinex DM (guaifenesin and dextromethorphan HBr) extended-release bi-layer tablets, 600…
Product was mis-packed. 40-count bottle was packaged in an individual carton indicating a 20-count volume.
Apr 2, 2007Class IID-797-2007Children''s Mucinex Expectorant (Guaifenesin, USP, 100mg/5mL), Grape Flavor Liquid, 4 fl… and 1 more product
Misbranded; calibrated dosage dispensing cup may be confusing to consumers as measurements are shown in units of teaspoon and tablespoon…

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 22, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

4 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIMar 4, 201310 years or older, so it adds no points0
Inspection classified OAIJan 5, 201110 years or older, so it adds no points0
Inspection classified VAIFeb 10, 201010 years or older, so it adds no points0
Class II recall D-797-2007, this FEI as the recalling firmApr 2, 200710 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 22, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 22, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 22, 2026Newest record Nov 13, 2026Current
Warning letter textNov 22, 2026Newest record Nov 17, 2026Current
Recalls (Enforcement Report)Nov 22, 2026Newest record Nov 18, 2026Current
Form 483s and inspection documentsNov 18, 2026Newest record Nov 17, 2026Current
Import refusalsNov 22, 2026Newest record Nov 12, 2026Current

Reviewing Reckitt Benckiser, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Reckitt Benckiser, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Reckitt Benckiser, Inc.
Location
Fort Worth, TX (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.